Clinical comparative study of dose–volume and equivalent uniform dose based predictions in post radiotherapy acute complications

References

• Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991; 21: 109–22
   PubMed Web of Science ®Google Scholar
• Schinkel C, Stavrev P, Stavreva N, Fallone BG. A theoretical approach to the problem of dose-volume constraint estimation and their impact on the dose-volume histogram selection. Med Phys 2006; 33: 3444–5
   PubMedGoogle Scholar
• Dawson LA, Biersack M, Lockwood G, Eisbruch A, Lawrence TS, Ten Haken RK. Use of principal component analysis to evaluate the partial organ tolerance of normal tissues to radiation. Int J Radiat Oncol Biol Phys 2005; 62: 829–37
   PubMed Web of Science ®Google Scholar
• Munley MT, Lo JY, Sibley GS, Bentel GC, Anscher MS, Marks LB. A neural network to predict symptomatic lung injury. Phys Med Biol 1999; 44: 2241–9
   PubMedGoogle Scholar
• Niemierko A. A generalized concept of equivalent uniform dose (EUD). Med Phys 1999; 26: 1100
   Google Scholar
• Das SK, Baydush AH, Zhou S, Miften M, Yu X, Craciunescu O, et al. Predicting radiotherapy-induced cardiac perfusion defects. Med Phys 2005; 32: 19–27
   PubMed Web of Science ®Google Scholar
• Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341–6
   PubMed Web of Science ®Google Scholar
• Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29–36
   PubMed Web of Science ®Google Scholar
• Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839–43
   PubMed Web of Science ®Google Scholar
• Lyman JT, Wolbarst AB. Optimization of radiation therapy, IV: A dose-volume histogram reduction algorithm. Int J Radiat Oncol Biol Phys 1989; 17: 433–6
   PubMed Web of Science ®Google Scholar
• Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991; 21: 123–35
   PubMed Web of Science ®Google Scholar
• Peeters ST, Hoogeman MS, Heemsbergen WD, Slot A, Tabak H, Koper PC, et al. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2005; 63: 1142–52
   PubMed Web of Science ®Google Scholar
• Peeters ST, Heemsbergen WD, van Putten WL, Slot A, Tabak H, Mens JW, et al. Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 2005; 61: 1019–34
   PubMed Web of Science ®Google Scholar
• Karlsdóttir A, Johannessen DC, Muren LP, Wentzel-Larsen T, Dahl O, et al. Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer. Radiother Oncol 2004; 71: 43–53
   PubMed Web of Science ®Google Scholar
• Nuyttens JJ, Milito S, Rust PF, Turrisi AT. Dose-volume relationship for acute side effects during high dose conformal radiotherapy for prostate cancer. Radiother Oncol 2002; 64: 209–14
   PubMedGoogle Scholar
• Cheng JC, Schultheiss TE, Nguyen KH, Wong JY. Acute toxicity in definitive versus postprostatectomy image-guided radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2008; 71: 351–7
   PubMed Web of Science ®Google Scholar
• Odrázcka K, Vanásek J, Vaculíková M, Petera J, Zouhar M, Zoul Z, et al. Conformal radiotherapy for prostate cancer—Longer duration of acute genitourinary toxicity in patients with prior history of invasive urological procedure. Acta Oncol 2001; 40: 810–5
   PubMedGoogle Scholar
• Zelefsky MJ, Fuks Z, Hunt M, Yamada Y, Marion C, Ling CC, et al. High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002; 53: 1111–6
   PubMed Web of Science ®Google Scholar
• Sanguineti GA., Endres EJ, Parker BC, Bicquart C, Little M, Chen G, et al. Acute toxicity of whole-pelvis IMRT in 87 patients with localized prostate cancer. Acta Oncol 2008; 47: 301–10
   PubMed Web of Science ®Google Scholar
• Meijer GJ, Van den Brink M, Hoogeman MS, Meinders J, Lebesque JV. Dose-wall histograms and normalized dose-surface histograms for the rectum: A new method to analyze the dose distribution over the rectum in conformal radiotherapy. Int J Radiat Oncol Biol Phys 1999; 45: 1073–80
   PubMedGoogle Scholar
• Tho LM, Glegg M, Paterson J, Yap C, MacLeod A, McCabe M, et al. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: Investigating dose-volume relationships and role for inverse planning. Int J Radiat Oncol Biol Phys 2006; 66: 505–13
   PubMed Web of Science ®Google Scholar
• Park CS, Kim Y, Lee N, Bucci KM, Quivey JM, Verhey LJ, et al. Method to account for dose fractionation in analysis of IMRT plans: Modified equivalent uniform dose. Int J Radiat Oncol Biol Phys 2005; 62: 925–32
   PubMedGoogle Scholar